Maribavir vs ganciclovir
Acute rejection · solid organ transplant recipients
Maribavir showed no clear difference in acute rejection compared with ganciclovir (low certainty).
1 finding from 1 review
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes onlyRR 0.92 [0.53, 1.61]1 study · 303 participantsLow